Peer review reports
From: Podocalyxin is a marker of poor prognosis in colorectal cancer
Original Submission | ||
---|---|---|
20 Dec 2013 | Submitted | Original manuscript |
30 Dec 2013 | Author responded | Author comments - Tuomas Kaprio |
Resubmission - Version 2 | ||
30 Dec 2013 | Submitted | Manuscript version 2 |
5 Feb 2014 | Reviewed | Reviewer Report - Konstantinos Konstantopoulos |
9 Feb 2014 | Reviewed | Reviewer Report - marius nap |
5 Mar 2014 | Author responded | Author comments - Tuomas Kaprio |
Resubmission - Version 3 | ||
5 Mar 2014 | Submitted | Manuscript version 3 |
19 Mar 2014 | Author responded | Author comments - Tuomas Kaprio |
Resubmission - Version 4 | ||
19 Mar 2014 | Submitted | Manuscript version 4 |
4 Apr 2014 | Author responded | Author comments - Tuomas Kaprio |
Resubmission - Version 5 | ||
4 Apr 2014 | Submitted | Manuscript version 5 |
23 May 2014 | Author responded | Author comments - Tuomas Kaprio |
Resubmission - Version 6 | ||
23 May 2014 | Submitted | Manuscript version 6 |
24 Jun 2014 | Author responded | Author comments - Tuomas Kaprio |
Resubmission - Version 7 | ||
24 Jun 2014 | Submitted | Manuscript version 7 |
Publishing | ||
2 Jul 2014 | Editorially accepted | |
8 Jul 2014 | Article published | 10.1186/1471-2407-14-493 |